Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Omega-3 in Women with History of Breast Cancer
NCT02278965Phase 1Completed
- Start
- Jan 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of liquid metformin (Aspargo Labs) and omega-3 fatty acid in breast cancer. Primary endpoint: Number of participants successfully completing the 1-year intervention. Started Jan 2015; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)omega-3 fatty acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02278965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02278965.